Annual International Congress IDMP & Regulatory Excellence

Whereas some pharmaceutical companies are now already collecting data for future IDMP submissions, others are still in the preparatory phases, analyzing how to obtain data from different internal and external data sources. Depending on the outcomes of the analysis phase, especially the number and complexity of internal databases to be integrated, companies will decide for a solution architecture that is more or less able to integrate the data from wherever it resides; a wide spectrum of solution architectures ? from stand-alone IDMP data bases, integral to integrated architectures will be chosen.

Termin: 

12.09.2016 -  14.09.2016